Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00738621 · ClinicalTrials.gov registry record · Phase 4
Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery Patients
A Phase 4 study of Postoperative Nausea and Vomiting, sponsored by Scott and White Hospital & Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT00738621: Completed Phase 4 study of Postoperative Nausea and Vomiting, sponsored by Scott and White Hospital & Clinic.
NCT00738621 is a Phase 4 study of Postoperative Nausea and Vomiting that has completed, run by Scott and White Hospital & Clinic. The registered enrollment target is 100 participants, below the 424-participant average among 10 other Postoperative Nausea and Vomiting trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00738621, a Phase 4 study of Postoperative Nausea and Vomiting, has completed, sponsored by Scott and White Hospital & Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the efficacy of the use of oral aprepitant in combination with intravenous ondansetron and dexamethasone with the efficacy provided by the use of oral aprepitant and dexamethasone for preventing vomiting during the first 24-48 hours after breast surgery.
Conditions Studied
Interventions
- DRUG Aprepitant, Dexamethasone, Ondansetron
- DRUG Aprepitant, Dexamethasone, Placebo
Study Locations (1)
Texas
- Scott and White Healthcare - Temple
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-08 |
| Phase | Phase 4 |
What the finished NCT00738621 record still lists
NCT00738621 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 424-participant average among 10 other Postoperative Nausea and Vomiting trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Postoperative Nausea and Vomiting appearing as the primary indexed condition, and to 2 interventions - of which Aprepitant, Dexamethasone, Ondansetron is the first listed.
NCT00738621 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00738621 about?
NCT00738621 is a clinical study titled "Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery Patients". The purpose of this study is to compare the efficacy of the use of oral aprepitant in combination with intravenous ondansetron and dexamethasone with the efficacy provided by the use of oral aprepitant and dexamethasone for preventing vomiting during the first 24-48 hours after breast surgery.
What is the current status of trial NCT00738621?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2008-07. Estimated completion is 2010-08.
What conditions does trial NCT00738621 study?
This clinical trial studies the following conditions: Postoperative Nausea and Vomiting.
What interventions are being tested in trial NCT00738621?
The interventions under investigation include: Aprepitant, Dexamethasone, Ondansetron (DRUG), Aprepitant, Dexamethasone, Placebo (DRUG).
Who is sponsoring clinical trial NCT00738621?
This trial is sponsored by Scott and White Hospital & Clinic, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00738621 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Nausea and Vomiting
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00738621's enrollment target sits among peer trials
100 8th of 10 the lowest of 10 other Postoperative Nausea and Vomiting trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Nausea and Vomiting trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Use of Transcutaneous Electrical Nerve Stimulation Device, Reletex Reliefband, With Current ERAS (Enhanced Recovery After Surgery) Protocol to Further Decrease Postoperative Nausea and Vomiting in the Bariatric Surgical Patient Within the First 24 Hours Postoperatively.
RECRUITING · NA
-
Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery
RECRUITING · Phase 2
-
A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea and Vomiting in the Bariatric Surgery Population
RECRUITING · Phase 3
-
Costs of Postoperative Nausea and Vomiting in Ambulatory Surgery Patients
COMPLETED
-
Clinical Use of Baxter Animated Retching Faces (BARF) Scale in Children
COMPLETED
-
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia